SMK/SM88 toxicity, efficacy, and patient reported outcomes in metastatic pancreas cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e14060
Abstract: e14060Background: SMK/SM-88 is a combination of novel tyrosine isomer (TI) and 3 low dose repurposed agents that are generally recognized as safe for typical use. Its mechanism of action is based o... read more here.
Keywords: efficacy patient; smk; toxicity efficacy; smk sm88 ... See more keywords